Fast Five Quiz: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Management

Jafar Kafaie, MD, PhD;  Christopher Luzzio, MD


August 31, 2023

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the most common chronic immune-mediated inflammatory polyneuropathy. The condition is characterized by symmetrical involvement, with proximal and distal muscle weakness. The course is progressive, relapsing-remitting, or monophasic. In addition to typical CIPD, there are atypical subtypes of disease, or variants, which might have distinct immunopathogenesis and treatment responses.

CIDP is a causally treatable form of acquired neuropathy. The mainstay of treatment is immunosuppressive or immunomodulatory intervention, and if associated conditions are identified (HIV infection, lupus, paraproteinemia, and lymphoma), co-management of these diseases is indicated as well.

How familiar are you with CIDP? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.